- call +1-201-465-4211
- email sales@mrinsights.biz
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
Scope of the Report:
The global average price of Drugs for Schistosomiasis is in the decreasing trend, from 62 USD/K Units in 2011 to 57 USD/K Units in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Drugs for Schistosomiasis is Praziquantel, Oxamniquine and other. Praziquantel is the mainly drug for Schistosomiasis, and the proportion of Praziquantel in 2015 is about 90%.
Drugs for Schistosomiasis are widely used in S. haematobium, S. mansoni, S. japonicum, S. mekongi and S. intercalatum.Most of human infections are caused by S. haematobium, S. mansoni, S. japonicum. And the market share used in S. haematobium in 2015 is 28%. And the market share used in S. mansoni in 2015 is 48%.
The worldwide market for Drugs for Schistosomiasis is expected to grow at a CAGR of roughly 5.6% over the next five years, will reach 100 million US$ in 2024, from 70 million US$ in 2019, according to a new study.
This report focuses on the Drugs for Schistosomiasis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Praziquantel
Oxamniquine
Other
Market Segment by Applications, can be divided into
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Schistosomiasis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for Schistosomiasis, with price, sales, revenue and global market share of Drugs for Schistosomiasis in 2017 and 2018.
Chapter 3, the Drugs for Schistosomiasis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Schistosomiasis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Drugs for Schistosomiasis market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Drugs for Schistosomiasis sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Drugs for Schistosomiasis Introduction
1.2 Market Analysis by Type
1.2.1 Praziquantel
1.2.2 Oxamniquine
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 S. haematobium
1.3.2 S. mansoni
1.3.3 S. japonicum
1.3.4 S. mekongi
1.3.5 S. intercalatum
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shin Poong
2.1.1 Business Overview
2.1.2 Drugs for Schistosomiasis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck
2.2.1 Business Overview
2.2.2 Drugs for Schistosomiasis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Drugs for Schistosomiasis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 EIPICO
2.4.1 Business Overview
2.4.2 Drugs for Schistosomiasis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Chandra Bhagat Pharma
2.5.1 Business Overview
2.5.2 Drugs for Schistosomiasis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Taj Pharmaceuticals
2.6.1 Business Overview
2.6.2 Drugs for Schistosomiasis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Drugs for Schistosomiasis Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Drugs for Schistosomiasis Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Drugs for Schistosomiasis Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2018
3.3.2 Top 6 Drugs for Schistosomiasis Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Drugs for Schistosomiasis Market Analysis by Regions
4.1 Global Drugs for Schistosomiasis Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Schistosomiasis Sales and Market Share by Regions (2014-2019)
4.1.2 Global Drugs for Schistosomiasis Revenue and Market Share by Regions (2014-2019)
4.2 North America Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
4.3 Europe Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
4.5 South America Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
5 North America Drugs for Schistosomiasis by Country
5.1 North America Drugs for Schistosomiasis Sales, Revenue and Market Share by Country
5.1.1 North America Drugs for Schistosomiasis Sales and Market Share by Country (2014-2019)
5.1.2 North America Drugs for Schistosomiasis Revenue and Market Share by Country (2014-2019)
5.2 United States Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
5.3 Canada Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
5.4 Mexico Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
6 Europe Drugs for Schistosomiasis by Country
6.1 Europe Drugs for Schistosomiasis Sales, Revenue and Market Share by Country
6.1.1 Europe Drugs for Schistosomiasis Sales and Market Share by Country (2014-2019)
6.1.2 Europe Drugs for Schistosomiasis Revenue and Market Share by Country (2014-2019)
6.2 Germany Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
6.3 UK Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
6.4 France Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
6.5 Russia Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
6.6 Italy Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
7 Asia-Pacific Drugs for Schistosomiasis by Country
7.1 Asia-Pacific Drugs for Schistosomiasis Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Drugs for Schistosomiasis Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Drugs for Schistosomiasis Revenue and Market Share by Country (2014-2019)
7.2 China Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
7.3 Japan Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
7.4 Korea Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
7.5 India Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
8 South America Drugs for Schistosomiasis by Country
8.1 South America Drugs for Schistosomiasis Sales, Revenue and Market Share by Country
8.1.1 South America Drugs for Schistosomiasis Sales and Market Share by Country (2014-2019)
8.1.2 South America Drugs for Schistosomiasis Revenue and Market Share by Country (2014-2019)
8.2 Brazil Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
8.3 Argentina Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
8.4 Colombia Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
9 Middle East and Africa Drugs for Schistosomiasis by Countries
9.1 Middle East and Africa Drugs for Schistosomiasis Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Drugs for Schistosomiasis Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Drugs for Schistosomiasis Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
9.3 Turkey Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
9.4 Egypt Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
9.5 Nigeria Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
9.6 South Africa Drugs for Schistosomiasis Sales and Growth Rate (2014-2019)
10 Global Drugs for Schistosomiasis Market Segment by Type
10.1 Global Drugs for Schistosomiasis Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Drugs for Schistosomiasis Sales and Market Share by Type (2014-2019)
10.1.2 Global Drugs for Schistosomiasis Revenue and Market Share by Type (2014-2019)
10.2 Praziquantel Sales Growth and Price
10.2.1 Global Praziquantel Sales Growth (2014-2019)
10.2.2 Global Praziquantel Price (2014-2019)
10.3 Oxamniquine Sales Growth and Price
10.3.1 Global Oxamniquine Sales Growth (2014-2019)
10.3.2 Global Oxamniquine Price (2014-2019)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2014-2019)
10.4.2 Global Other Price (2014-2019)
11 Global Drugs for Schistosomiasis Market Segment by Application
11.1 Global Drugs for Schistosomiasis Sales Market Share by Application (2014-2019)
11.2 S. haematobium Sales Growth (2014-2019)
11.3 S. mansoni Sales Growth (2014-2019)
11.4 S. japonicum Sales Growth (2014-2019)
11.5 S. mekongi Sales Growth (2014-2019)
11.6 S. intercalatum Sales Growth (2014-2019)
12 Drugs for Schistosomiasis Market Forecast (2019-2024)
12.1 Global Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2019-2024)
12.2 Drugs for Schistosomiasis Market Forecast by Regions (2019-2024)
12.2.1 North America Drugs for Schistosomiasis Market Forecast (2019-2024)
12.2.2 Europe Drugs for Schistosomiasis Market Forecast (2019-2024)
12.2.3 Asia-Pacific Drugs for Schistosomiasis Market Forecast (2019-2024)
12.2.4 South America Drugs for Schistosomiasis Market Forecast (2019-2024)
12.2.5 Middle East and Africa Drugs for Schistosomiasis Market Forecast (2019-2024)
12.3 Drugs for Schistosomiasis Market Forecast by Type (2019-2024)
12.3.1 Global Drugs for Schistosomiasis Sales Forecast by Type (2019-2024)
12.3.2 Global Drugs for Schistosomiasis Market Share Forecast by Type (2019-2024)
12.4 Drugs for Schistosomiasis Market Forecast by Application (2019-2024)
12.4.1 Global Drugs for Schistosomiasis Sales Forecast by Application (2019-2024)
12.4.2 Global Drugs for Schistosomiasis Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Drugs for Schistosomiasis Picture
Table Product Specifications of Drugs for Schistosomiasis
Figure Global Sales Market Share of Drugs for Schistosomiasis by Types in
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
